{"Symbol": "VRTX", "AssetType": "Common Stock", "Name": "Vertex Pharmaceuticals Inc", "Description": "Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.", "CIK": "875320", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "PHARMACEUTICAL PREPARATIONS", "Address": "50 NORTHERN AVENUE, BOSTON, MA, US", "OfficialSite": "https://www.vrtx.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "126090519000", "EBITDA": "4774600000", "PERatio": "None", "PEGRatio": "1.345", "BookValue": "63.87", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-2.06", "RevenuePerShareTTM": "42.73", "ProfitMargin": "-0.0486", "OperatingMarginTTM": "0.45", "ReturnOnAssetsTTM": "0.127", "ReturnOnEquityTTM": "-0.0315", "RevenueTTM": "11020100000", "GrossProfitTTM": "6024300000", "DilutedEPSTTM": "-2.06", "QuarterlyEarningsGrowthYOY": "-0.056", "QuarterlyRevenueGrowthYOY": "0.157", "AnalystTargetPrice": "500.32", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "16", "AnalystRatingHold": "12", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "1", "TrailingPE": "-", "ForwardPE": "27.86", "PriceToSalesRatioTTM": "11.44", "PriceToBookRatio": "7.68", "EVToRevenue": "11.05", "EVToEBITDA": "250.31", "Beta": "0.506", "52WeekHigh": "519.88", "52WeekLow": "377.85", "50DayMovingAverage": "486.57", "200DayMovingAverage": "471.05", "SharesOutstanding": "257081000", "DividendDate": "None", "ExDividendDate": "None"}